Document:

Filing

Existing Samples Purchase Agreement Schedules, executed October 13, 2006, between the Company and CorCell, Inc.

EX-10.77

SCHEDULE 1(A)

ADDITIONAL ACQUIRED ASSETS

·

Coriell Equipment (Attachment) 

·

Existing Specimen Samples (Attachment)Filing

Bill Of Sale, executed October 13, 2006, between the Company and CorCell, Inc.

EX-10.78

BILL OF SALE

THIS BILL OF SALE is made and entered into to be effective as of the 12th day of October, 2006, by CorCell, Inc., a Delaware corporation (“Seller”) in favor of Cord Blood America, Inc., a Florida corporation (“Buyer”).

BACKGROUND

This Bill of Sale is made pursuant to the Asset Purchase Agreement (the “Asset Purchase Agreement”) by and between Seller and Buyer, of even date herewith, to transfer certain Acquired Assets, as fully defined therein. 

NOW, THEREFORE, in consideration of the premises, the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, Seller hereby acts and agrees as follows:

1.

Conveyance and Assignment. Seller hereby sells, conveys, transfers, assigns and delivers unto Buyer and its successors and assigns, the Acquired Assets, as described and defined in Section 1 of the Asset Purchase Agreement.  By the acceptance of the Acquired Assets, Buyer assumes all liabilities and obligations of Seller as set forth and limited in the Asset Purchase Agreement.  All right, title and interest of Seller in the Acquired Assets conveyed hereby are conveyed to Buyer.

2.

Power of Attorney.  Seller hereby constitutes and appoints Buyer as Seller’s true and lawful attorney, with full power of substitution, for it and in its name, place and stead, or otherwise, but on behalf of and for the benefit of Buyer, to demand and receive from time to time any and all of the Acquired Assets, hereby sold, assigned and conveyed, or intended so to be, and to get receipts and releases for and in respect of the same or any part thereof, and from time to time to institute and prosecute in the name of Seller or otherwise, but at the expense and for the benefit of Buyer, any and all proceedings at law, in equity or otherwise, that Buyer may deem proper in order to assert or enforce any claim, right or title, of any kind, in and to the property, assets, rights and privileges hereby assigned and conveyed, or intended so to be, and to defend and compromise any and all actions, suits or proceedings in respect of any of the said property, assets, rights and privileges, and generally to do all and any such acts and things in relation thereto as Buyer shall deem advisable, including without limitation the assignment of title to any motor vehicles.

3.

Further Assurances.  From time to time, as and when requested by Buyer, Seller shall execute and deliver, or cause to be executed and delivered, such documents and instruments and shall take, or cause to be taken, such further or other actions as may be reasonably necessary to carry out the purposes of this Bill of Sale.

4.

Controlling Agreement.  It is contemplated that Seller may, at any time or from time to time, execute, acknowledge and deliver one or more separate instruments of assignment and conveyance relating to certain of the Acquired Assets.  No such separate instrument of assignment or conveyance shall limit the scope and effect of this Bill of Sale. 

5.

Governing Law.  The validity of this Bill of Sale shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws principles thereof.

6.

Successors and Assigns.  This Bill of Sale shall bind Seller and its successors and assigns and inure to the benefit of Buyer and its successors and assigns.

7.

Descriptive Headings.  The descriptive headings of the several paragraphs, subparagraphs and clauses of this Bill of Sale were inserted for convenience only and shall not be deemed to affect the meaning or construction of any of the provisions hereof.

IN WITNESS WHEREOF, the undersigned have executed this Bill of Sale of the day and year first above written.

SELLER:

			
	 
	CORCELL, INC., 

a Delaware corporation

	 
	 

	 
	By:

	/s/ Marcia A. Laleman

	 
	Name:

	Marcia A. Laleman

	 
	Title: 

	President

BUYER:

			
	 
	CORD BLOOD AMERICA, INC., 

a Florida corporation

	 
	 

	 
	By:

	/s/ Matthew Schissler

	 
	Name:

	Matthew Schissler

	 
	Title: 

	Chairman and Chief Executive OfficerFiling

Assumption Agreement, executed October 13, 2006, between the Company and CorCell, Inc.

EX-10.79

ASSIGNMENT AND ASSUMPTION AGREEMENT

THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (the “Agreement”) is made and entered into to be effective as of the 12th day of October, 2006, by and between CorCell, Inc., a Delaware corporation (“Seller”), and Cord Blood America, Inc., a Florida corporation (“Buyer”).

BACKGROUND

This Agreement is made pursuant to the Asset Purchase Agreement (the “Asset Purchase Agreement”) of even date herewith by and between Seller and Buyer, in which Seller is concurrently herewith selling, transferring, conveying, assigning and delivering to Buyer the Acquired Assets, as defined in the Asset Purchase Agreement.  Capitalized terms used and not defined herein shall have the meanings given to them in the Asset Purchase Agreement.

Pursuant to the Asset Purchase Agreement, as part of the consideration for the Acquired Assets, Buyer is required to assume and agree to perform, pay or discharge, when due, certain Assumed Obligations, as defined in the Asset Purchase Agreement.

NOW, THEREFORE, in consideration of the premises, the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereby covenant and agree as follows:

1.

Seller herby assigns, and Buyer hereby assumes and agrees to pay, perform and discharge, in accordance with their terms, the Assumed Obligations.

2.

The assumption by Buyer of the Assumed Obligations shall not be construed to defeat, impair or limit in any way the rights, claims or remedies of Buyer under the Asset Purchase Agreement.

3.

Nothing contained herein shall change, amend, extend or alter (nor shall it be deemed or construed as changing, amending, extending or altering) the terms or conditions of the Asset Purchase Agreement in any manner whatsoever.  This instrument does not create or establish liabilities or obligations not otherwise created or existing under or pursuant to the Asset Purchase Agreement.  In the event of any conflict or other difference between the Asset Purchase Agreement and this instrument, the provisions of the Asset Purchase Agreement shall control.

4.  Nothing contained herein shall confer any rights on any third party or in any way enhance or expand the rights of any third party with respect to any of the Assumed Obligations, and Buyer reserves any and all defenses, rights of offset, claims and counterclaims that either the Seller or Buyer may have with respect to any of the Assumed Obligations.

5.  This Agreement shall be construed and enforced in accordance with, and governed by, the laws of the State of Delaware applicable to contracts to be performed entirely within that state, without giving effect to the principles of conflicts of law thereof.

6.  This Agreement shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and assigns; provided, however, that no party may assign any of its rights or delegate any of its duties under this Agreement without the prior written consent of the other parties hereto.  

IN WITNESS WHEREOF, the undersigned have executed this Assignment and Assumption Agreement as of the day and year first above written.

SELLER:

			
	 
	CORCELL, INC., 

a Delaware corporation

	 
	 

	 
	By:

	/s/ Marcia A. Laleman

	 
	Name:

	Marcia A. Laleman

	 
	Title: 

	President

BUYER:

			
	 
	CORD BLOOD AMERICA, INC., 

a Florida corporation

	 
	 

	 
	By:

	/s/ Matthew Schissler

	 
	Name:

	Matthew Schissler

	 
	Title: 

	Chairman and Chief Executive OfficerExhibit 10.80

TRADEMARK ASSIGNMENT AGREEMENT

WHEREAS, CorCell, Inc., a Delaware corporation, having a place of business at 1717 Arch Street, Suite 1410, Philadelphia, PA 19103, (hereinafter “CorCell”), has adopted and used the trademarks and service marks listed in Schedule “A” attached hereto (hereinafter the “Marks”); 

WHEREAS, certain of the Marks are registered in the United States Patent and Trademark Office;

WHEREAS, CorCell is owner of the United States Trademark and Service Mark Registrations set forth  in Schedule “A” hereto (hereinafter “Registrations”); and

WHEREAS, Cord Blood America, Inc., a Florida corporation, having a place of business at 9000 Sunset Boulevard, Suite 400, Los Angeles, CA  90069 (hereinafter “CBA”), is desirous of acquiring said Marks and Registrations, together with the goodwill of the business associated therewith. 

NOW, THEREFORE, for good valuable consideration, the full receipt and sufficiency all of which are hereby acknowledged, and intending to be legally bound hereby:  

1.

CorCell hereby assigns, transfers and conveys to CBA, CorCell’s entire right, title and interest in and to said Marks and Registrations, together with the goodwill of CorCell’s business associated therewith;

2.

CorCell hereby assigns to CBA all causes of action, claims and rights to damages or profits, due or accrued, arising out of past infringement of the Marks and Registrations, or 

i

injury to the goodwill associated with the Marks and Registrations, as well as the rights to sue for and recover the Marks and Registrations in CBA’s own name; and

3.

CorCell represents and warrants that it will reasonably cooperate (i) in any actions necessary for CBA to prosecute, renew or register its rights, title and interests in and to the Marks and Registrations, including United States and foreign registrations, at CBA’s expense (except to the extent that CorCell is required to indemnify CBA for any of the above actions pursuant to the Asset Purchase Agreement dated October __, 2006, to which CorCell and CBA are parties (the “Purchase Agreement”)), and (ii) in any actions brought to enforce the rights accompanying this Assignment against third parties, at CBA’s expense (except to the extent that CorCell is required to indemnify CBA for any of the above actions pursuant to the Purchase Agreement).

4.

Upon information and belief, the Registrations listed on Schedule “A” hereto will expire on the dates listed under the heading entitled “Expiration Date.”

5.

Upon information and belief, CorCell has not discontinued the use, with an intention not to resume use, of the Marks listed in Schedule “A” hereto.

IN WITNESS WHEREOF, CorCell has caused this Trademark Assignment Agreement to be executed by its duly authorized representative on the date last set forth below.

			
	 
	CORCELL, INC., 

a Delaware corporation

	 
	 

	 
	By:

	/s/ Marcia A. Laleman

	 
	Name:

	Marcia A. Laleman

	 
	Title: 

	President

ii

SCHEDULE A

UNITED STATES TRADEMARK AND SERVICE MARK REGISTRATIONS 

in the name of CorCell Inc.

					
	Mark

	Registration

No.

	Registration

Date

	Int’l

Classification

	Expiration 

Date

	EXPECTATIONS

	2,993,161

	09/06/2005

	9, 16, 42

	09/06/2015

	SAVING BABY’S CORD BLOOD

	2,962,036

	06/14/2005

	44

	06/14/2015

	NOW, YOU CAN GIVE LIFE AND SAVE LIFE AT THE SAME TIME.

	2,889,134

	09/28/2004

	44

	09/28/2014

	FOR WHAT YOU’RE NOT EXPECTING.

	2,865,144

	07/20/2004

	44

	07/20/2014

	CORCELL (Stylized)

	2,901,663

	11/09/2004

	44

	11/09/2014

	CORCELL and Design

	2,906,423

	11/30/2004

	44

	11/30/2014

	YOUR BABY’S LIFELINE

	3,119,792

	07/25/2006

	39, 42

	07/25/2016

UNREGISTERED TRADEMARKS AND SERVICE MARKS 

in the name of CorCell Inc.

PUREPATHTM

iii

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]